Département d'Anesthésie-Réanimation, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, Université Claude Bernard, Lyon, France.
Département d'Anesthésie-Réanimation, Hôpital Louis Pradel, Hospices Civils de Lyon, Université Claude Bernard, France.
J Comp Eff Res. 2021 Jun;10(9):743-750. doi: 10.2217/cer-2020-0239. Epub 2021 Apr 21.
To evaluate the usability and satisfaction from the sufentanil sublingual tablet system analgesia in the Enhanced Recovery After Surgery pathway in patients, nurses and physical therapist. A system usability scale was used to evaluate analgesia system in the prospective observational study in spine, orthopedic and thoracic patients. In 111 cases the median system usability scale score was 90 (80-100) (patients) and 72.5 (57.5-82.5) (nurses). The median satisfaction score of the physiotherapist was 90 (75-100). The usability and the satisfaction of the patients and the caregivers from sufentanil sublingual tablet system analgesia in the context of Enhanced Recovery After Surgery protocol were good-to-excellent. The economic potential in the reduction of hospital stay should be studied. Trial registration number: NCT03373851 (ClinicalTrial.gov).
为了评估在强化康复治疗路径中，舒芬太尼舌下片镇痛系统在患者、护士和物理治疗师中的可用性和满意度，我们采用系统可用性量表对脊柱、骨科和心胸患者进行前瞻性观察研究。在 111 例患者中，系统可用性量表评分为中位数 90（80-100）分，护士评分为中位数 72.5（57.5-82.5）分。物理治疗师的满意度评分为中位数 90（75-100）分。在强化康复治疗方案中，患者和护理人员对舒芬太尼舌下片镇痛系统的可用性和满意度评价良好到优秀。应研究该系统在缩短住院时间方面的潜在经济性。试验注册号：NCT03373851（ClinicalTrials.gov）。
